Your browser doesn't support javascript.
loading
The protein disulfide isomerases PDIA4 and PDIA6 mediate resistance to cisplatin-induced cell death in lung adenocarcinoma.
Tufo, G; Jones, A W E; Wang, Z; Hamelin, J; Tajeddine, N; Esposti, D D; Martel, C; Boursier, C; Gallerne, C; Migdal, C; Lemaire, C; Szabadkai, G; Lemoine, A; Kroemer, G; Brenner, C.
Affiliation
  • Tufo G; 1] INSERM UMR-S 769, LabEx LERMIT, Châtenay-Malabry, France [2] Faculté de Pharmacie, Université de Paris-Sud, Châtenay-Malabry, France.
  • Jones AW; Department of Cell and Developmental Biology, University College London, London, UK.
  • Wang Z; 1] INSERM UMR-S 769, LabEx LERMIT, Châtenay-Malabry, France [2] Faculté de Pharmacie, Université de Paris-Sud, Châtenay-Malabry, France.
  • Hamelin J; APHP Hôpital P. Brousse, Biochimie et oncogénétique, INSERM U1004, Villejuif, France.
  • Tajeddine N; INSERM U848, Institut Gustave Roussy, Université Paris-Sud 11, PR1, 39 rue Camille Desmoulins, Villejuif, France.
  • Esposti DD; APHP Hôpital P. Brousse, Biochimie et oncogénétique, INSERM U1004, Villejuif, France.
  • Martel C; 1] INSERM UMR-S 769, LabEx LERMIT, Châtenay-Malabry, France [2] Faculté de Pharmacie, Université de Paris-Sud, Châtenay-Malabry, France [3] Montreal Heart Institute, Centre de Recherche, Montreal, Quebec, Canada.
  • Boursier C; IFR 141-IPSIT, Châtenay-Malabry, France.
  • Gallerne C; 1] INSERM UMR-S 769, LabEx LERMIT, Châtenay-Malabry, France [2] Faculté de Pharmacie, Université de Paris-Sud, Châtenay-Malabry, France.
  • Migdal C; 1] Faculté de Pharmacie, Université de Paris-Sud, Châtenay-Malabry, France [2] INSERM U 996, Châtenay-Malabry, France.
  • Lemaire C; 1] INSERM UMR-S 769, LabEx LERMIT, Châtenay-Malabry, France [2] Department of Biology, University of Versailles-St Quentin, Versailles, France.
  • Szabadkai G; 1] Department of Cell and Developmental Biology, University College London, London, UK [2] Department of Biomedical Sciences, University of Padua, Padua, Italy.
  • Lemoine A; APHP Hôpital P. Brousse, Biochimie et oncogénétique, INSERM U1004, Villejuif, France.
  • Kroemer G; 1] INSERM U848, Institut Gustave Roussy, Université Paris-Sud 11, PR1, 39 rue Camille Desmoulins, Villejuif, France [2] Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France [3] Metabolomics Platform, Institut Gustave Roussy, Villejuif, France [4] Equipe 11 labellisée par la Ligue c
  • Brenner C; 1] INSERM UMR-S 769, LabEx LERMIT, Châtenay-Malabry, France [2] Faculté de Pharmacie, Université de Paris-Sud, Châtenay-Malabry, France.
Cell Death Differ ; 21(5): 685-95, 2014 May.
Article in En | MEDLINE | ID: mdl-24464223
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Adenocarcinoma / Cisplatin / Protein Disulfide-Isomerases / Lung Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Cell Death Differ Year: 2014 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Adenocarcinoma / Cisplatin / Protein Disulfide-Isomerases / Lung Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Cell Death Differ Year: 2014 Document type: Article